HUP0302923A3 - Process for the phase transfer catalyzed glycosidation of indolocarbazole derivatives - Google Patents

Process for the phase transfer catalyzed glycosidation of indolocarbazole derivatives

Info

Publication number
HUP0302923A3
HUP0302923A3 HU0302923A HUP0302923A HUP0302923A3 HU P0302923 A3 HUP0302923 A3 HU P0302923A3 HU 0302923 A HU0302923 A HU 0302923A HU P0302923 A HUP0302923 A HU P0302923A HU P0302923 A3 HUP0302923 A3 HU P0302923A3
Authority
HU
Hungary
Prior art keywords
phase transfer
indolocarbazole derivatives
transfer catalyzed
catalyzed glycosidation
glycosidation
Prior art date
Application number
HU0302923A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HUP0302923A2 publication Critical patent/HUP0302923A2/hu
Publication of HUP0302923A3 publication Critical patent/HUP0302923A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0302923A 2000-10-31 2001-10-26 Process for the phase transfer catalyzed glycosidation of indolocarbazole derivatives HUP0302923A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24467500P 2000-10-31 2000-10-31
PCT/US2001/047603 WO2002036601A2 (en) 2000-10-31 2001-10-26 Phase transfer catalyzed glycosidation of an indolocarbazole

Publications (2)

Publication Number Publication Date
HUP0302923A2 HUP0302923A2 (hu) 2003-12-29
HUP0302923A3 true HUP0302923A3 (en) 2005-02-28

Family

ID=22923680

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302923A HUP0302923A3 (en) 2000-10-31 2001-10-26 Process for the phase transfer catalyzed glycosidation of indolocarbazole derivatives

Country Status (21)

Country Link
US (2) US6555677B2 (hu)
EP (1) EP1333826A2 (hu)
JP (1) JP3554560B2 (hu)
KR (1) KR100813086B1 (hu)
CN (1) CN1240380C (hu)
AU (2) AU2894502A (hu)
BG (1) BG107737A (hu)
BR (1) BR0115036A (hu)
CA (1) CA2426815A1 (hu)
CZ (1) CZ20031209A3 (hu)
EA (1) EA005209B1 (hu)
HK (1) HK1064053A1 (hu)
HU (1) HUP0302923A3 (hu)
IL (1) IL155543A0 (hu)
IS (1) IS6791A (hu)
MX (1) MXPA03003871A (hu)
NO (1) NO20031922L (hu)
NZ (1) NZ525398A (hu)
PL (1) PL365574A1 (hu)
WO (1) WO2002036601A2 (hu)
ZA (1) ZA200303198B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555677B2 (en) * 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole
US7429572B2 (en) * 2003-05-30 2008-09-30 Pharmasset, Inc. Modified fluorinated nucleoside analogues
JPWO2005026185A1 (ja) * 2003-09-16 2006-11-16 萬有製薬株式会社 抗腫瘍性新規インドロピロロカルバゾール誘導体
WO2005116044A1 (ja) * 2004-05-28 2005-12-08 Banyu Pharmaceutical Co.,Ltd インドロピロロカルバゾール誘導体の製造法
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
SI3109244T1 (sl) * 2004-09-14 2019-06-28 Gilead Pharmasset Llc Priprava 2'fluoro-2'-alkil-substituiranih ali drugih neobvezno substituiranih ribofuranozil pirimidinov in purinov in njihovih derivatov
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
EA019341B1 (ru) 2008-12-23 2014-02-28 Джилид Фармассет, Ллс. Фосфорамидаты нуклеозидов
WO2010075554A1 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Synthesis of purine nucleosides
PA8855701A1 (es) 2008-12-23 2010-07-27 Análogos de nucleósidos
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
BR112012024884A2 (pt) 2010-03-31 2016-10-18 Gilead Pharmasset Llc síntese estereosseletiva de ativos contendo fósforo
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
EP2646453A1 (en) 2010-11-30 2013-10-09 Gilead Pharmasset LLC Compounds
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
PT3650014T (pt) 2013-08-27 2021-12-27 Gilead Pharmasset Llc Formulação combinada de dois compostos antivirais

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808613A (en) 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition
GB8818430D0 (en) * 1988-08-03 1988-09-07 Tate & Lyle Plc Process
US5668271A (en) 1991-11-29 1997-09-16 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
US5591842A (en) 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
NZ245203A (en) 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5437996A (en) 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
US5589365A (en) 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5468872A (en) 1993-09-16 1995-11-21 Cephalon, Inc. K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
EP0675125A1 (en) 1994-03-18 1995-10-04 Kyowa Hakko Kogyo Co., Ltd. A therapeutic agent for thrombocytopenia and indolocarbazole derivatives
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5804564A (en) 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
FR2750135B1 (fr) * 1996-06-20 1998-08-14 Ceca Sa Acides fluoroalkyl glycosides uroniques et lactones-6(3) correspondantes, preparation et utilisations
EP0971717B1 (en) 1996-08-22 2001-12-19 Bristol-Myers Squibb Company Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
US6555677B2 (en) * 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole

Also Published As

Publication number Publication date
HUP0302923A2 (hu) 2003-12-29
AU2894502A (en) 2002-05-15
NO20031922L (no) 2003-06-27
IL155543A0 (en) 2003-11-23
CZ20031209A3 (cs) 2003-10-15
PL365574A1 (en) 2005-01-10
NO20031922D0 (no) 2003-04-29
EA200300525A1 (ru) 2003-08-28
JP3554560B2 (ja) 2004-08-18
AU2002228945B2 (en) 2006-02-02
KR20030082545A (ko) 2003-10-22
CN1240380C (zh) 2006-02-08
IS6791A (is) 2003-04-16
US20040024196A1 (en) 2004-02-05
KR100813086B1 (ko) 2008-03-17
US20020058803A1 (en) 2002-05-16
HK1064053A1 (en) 2005-01-21
EA005209B1 (ru) 2004-12-30
CA2426815A1 (en) 2002-05-10
MXPA03003871A (es) 2003-07-28
US6555677B2 (en) 2003-04-29
CN1482908A (zh) 2004-03-17
EP1333826A2 (en) 2003-08-13
BG107737A (bg) 2004-01-30
WO2002036601A3 (en) 2002-11-28
ZA200303198B (en) 2004-04-23
BR0115036A (pt) 2004-02-25
JP2004513131A (ja) 2004-04-30
WO2002036601A2 (en) 2002-05-10
NZ525398A (en) 2004-12-24

Similar Documents

Publication Publication Date Title
HUP0302923A3 (en) Process for the phase transfer catalyzed glycosidation of indolocarbazole derivatives
GB0028179D0 (en) Process for preparing pouches
IL146579A0 (en) Process for the preparation of herbicidal derivatives
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
HUP0303443A3 (en) Process for the preparation of imidazole derivatives
HUP0203407A3 (en) Process for the preparation of pyrazolopyridazine derivatives
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
EP1176150A4 (en) A METHOD FOR PRODUCING TRIFLUOROTHYMIDINE DERIVATIVES
MXPA03001550A (es) Proceso catalitico para la preparacion de derivados de tiazol.
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL138691A (en) Process for the preparation of 3-acyl-indoles
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
AU2001241042A1 (en) Process for the preparation of hydrazine derivatives
EP1186612A4 (en) PROCESS FOR THE PREPARATION OF CYTIDIN DERIVATIVES
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
HUP0000208A3 (en) Process for producing secondary-alkoxy-1-alkene derivatives
HUP0101063A3 (en) Process for preparing alkoxytriazolinone derivatives
IL138343A0 (en) Process for the preparation of nitroguanidine derivatives
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
IL143239A0 (en) Process for preparing pyridazin-3-on derivatives
PL352099A1 (en) Process for the preparation of tetrafluorohalogenbenzenes
HUP0004154A3 (en) Process for the preparation of 1,5-disubstituted-3-amino-1,2,4-triazole derivatives